title: Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial.
authors.affiliation: Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Zinzani
authors.affiliation: Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.
authors.forename: Cinzia
authors.initials: C
authors.lastname: Pellegrini
authors.affiliation: Hematology Unit, Città della Salute e della Scienza Hospital and University, Turin, Italy.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Chiappella
authors.affiliation: Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
authors.forename: Alice
authors.initials: A
authors.lastname: Di Rocco
authors.affiliation: Department of Hematology, Ospedale SS Antonio e Biagio Alessandria, Alessandria, Italy; and.
authors.forename: Flavia
authors.initials: F
authors.lastname: Salvi
authors.affiliation: Hematology and Bone Marrow Transplantation Unit, "A. Businco" Cancer Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
authors.forename: Maria Giuseppina
authors.initials: MG
authors.lastname: Cabras
authors.affiliation: Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.
authors.forename: Lisa
authors.initials: L
authors.lastname: Argnani
authors.affiliation: Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.
authors.forename: Vittorio
authors.initials: V
authors.lastname: Stefoni
mesh_terms: D000328:Adult; D000368:Aged; D000079963:Brentuximab Vedotin; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage* / Q000009:adverse effects; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D008479:Mediastinal Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D008875:Middle Aged; D012008:Recurrence; D015996:Survival Rate
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin